Belgium· BE-AMP-SAM054677-00
Marcoumar 3 mg
A phenprocoumon product containing phenprocoumon, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Phenprocoumon is registered in 7 of 19 countries.
Countries holding a registration under ATC B01AA04 (phenprocoumon), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Phenprocoumon · ATC B01AA04
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of phenprocoumon costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Phenprocoumon · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.45
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Phenprocoumon
- Manufacturer
- Viatris Healthcare
- Country
- Belgium (BE)
- ATC code
- B01AA04
- ATC class
- Phenprocoumon
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0119065EUR 8.03
- be_apb0711291
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
82 interactions on record for phenprocoumon.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenprocoumon · interactions on record
82 records
82 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Phenprocoumon in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyFalithromLaboratorios Farmacéuticos Rovi, S.A
- SwitzerlandMarcoumar, TablettenViatris Pharma GmbH
- NetherlandsFenprocoumon Sandoz 3 mg, tablettenSandoz B.V.
- United KingdomMarcoumar 3mg tabletsImported (Germany)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Marcoumar
- Germany · Falithrom, Marcumar
- Luxembourg · Marcoumar
- Netherlands · Fenprocoumon Sandoz, Marcoumar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2bc8a94a-3a04-4f01-ae10-8599dfe536df GET /v1/drugs/2bc8a94a-3a04-4f01-ae10-8599dfe536df?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Marcoumar 3 mg",
"name_fr": "Marcoumar 3 mg",
"name_nl": "Marcoumar 3 mg",
"amp_code": "SAM054677-00",
"strengths": [
"3.0000",
"3.0000",
"3.0000",
"80.0000"
],
"pack_count": 1,
"substances": [
"Phenprocoumon",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Phenprocoumon",
"authorisation_numbers": [
"BE054677"
]
}See everything about phenprocoumon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.